116 related articles for article (PubMed ID: 1297232)
21. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM
J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma.
Planting AS; van der Burg ME; Goey SH; Schellens JH; van den Bent MJ; de Boer-Dennert M; Stoter G; Verweij J
Ann Oncol; 1995 Jul; 6(6):613-5. PubMed ID: 8573543
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma.
Fennell DA; Steele JP; Shamash J; Evans MT; Wells P; Sheaff MT; Rudd RM; Stebbing J
Cancer; 2007 Jan; 109(1):93-9. PubMed ID: 17146783
[TBL] [Abstract][Full Text] [Related]
24. NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
Gregorc V; Gaafar RM; Favaretto A; Grossi F; Jassem J; Polychronis A; Bidoli P; Tiseo M; Shah R; Taylor P; Novello S; Muzio A; Bearz A; Greillier L; Fontana F; Salini G; Lambiase A; O'Brien M
Lancet Oncol; 2018 Jun; 19(6):799-811. PubMed ID: 29753703
[TBL] [Abstract][Full Text] [Related]
25. [A case of malignant pleural mesothelioma and its sensitivity tests for anti-cancer drugs].
Asakura S; Matsui T; Tatsumi A; Fujio A; Kitano M; Kobashi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jul; 26(7):695-9. PubMed ID: 3149385
[No Abstract] [Full Text] [Related]
26. Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon.
Tansan S; Emri S; Selçuk T; Koç Y; Hesketh P; Heeren T; McCaffrey RP; Bariş YI
Oncology; 1994; 51(4):348-51. PubMed ID: 8208519
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
Ishihara Y; Ichiwata T; Kuramitsu K; Yoneda S; Yamamoto M; Takizawa T; Ogata T; Uchiyama T; Yoshida K
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1013-20. PubMed ID: 9644316
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study.
Knuuttila A; Ollikainen T; Halme M; Mali P; Kivisaari L; Linnainmaa K; Jekunen A; Mattson K
Anticancer Drugs; 2000 Apr; 11(4):257-61. PubMed ID: 10898540
[TBL] [Abstract][Full Text] [Related]
29. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
Einhorn LH; Loehrer PJ; Williams SD; Meyers S; Gabrys T; Nattan SR; Woodburn R; Drasga R; Songer J; Fisher W
J Clin Oncol; 1986 Jul; 4(7):1037-43. PubMed ID: 3088219
[TBL] [Abstract][Full Text] [Related]
30. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
[TBL] [Abstract][Full Text] [Related]
31. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Fujii M; Kiura K; Okabe K; Toki H; Kimura M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
[TBL] [Abstract][Full Text] [Related]
32. A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma.
Omasa M; Hirata T; Shoji T; Bando T; Hasegawa S; Inui K; Wada H
Thorac Cardiovasc Surg; 2001 Aug; 49(4):233-5. PubMed ID: 11505321
[TBL] [Abstract][Full Text] [Related]
33. Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
Buikhuisen WA; Burgers JA; Vincent AD; Korse CM; van Klaveren RJ; Schramel FM; Pavlakis N; Nowak AK; Custers FL; Schouwink JH; Gans SJ; Groen HJ; Strankinga WF; Baas P
Lancet Oncol; 2013 May; 14(6):543-51. PubMed ID: 23583604
[TBL] [Abstract][Full Text] [Related]
34. Nonselective transarterial chemoperfusion: a palliative treatment for malignant pleural mesothelioma.
Vogl TJ; Lindemayr S; Naguib NN; Gurung J; Nour-Eldin NE; Zangos S; Mbalisike EC
Radiology; 2013 Feb; 266(2):649-56. PubMed ID: 23151824
[TBL] [Abstract][Full Text] [Related]
35. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
Fizazi K; Doubre H; Le Chevalier T; Riviere A; Viala J; Daniel C; Robert L; Barthélemy P; Fandi A; Ruffié P
J Clin Oncol; 2003 Jan; 21(2):349-54. PubMed ID: 12525529
[TBL] [Abstract][Full Text] [Related]
36. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge].
Shukuya T; Takahashi T; Nakamura Y; Yamamoto N
Gan To Kagaku Ryoho; 2010 Mar; 37(3):487-90. PubMed ID: 20332689
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).
O'Brien ME; Gaafar RM; Popat S; Grossi F; Price A; Talbot DC; Cufer T; Ottensmeier C; Danson S; Pallis A; Hasan B; Van Meerbeeck JP; Baas P
Eur J Cancer; 2013 Sep; 49(13):2815-22. PubMed ID: 23791541
[TBL] [Abstract][Full Text] [Related]
38. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
Pérol M; Guérin JC; Thomas P; Poirier R; Carles P; Robinet G; Kleisbauer JP; Paillotin D; Vergnenègre A; Balmes P; Touron D; Grivaux M; Pham E
Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
[TBL] [Abstract][Full Text] [Related]
39. Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma.
Purohit A; Moreau L; Dietemann A; Seibert R; Pauli G; Wihlm JM; Quoix E
Lung Cancer; 1998 Nov; 22(2):119-25. PubMed ID: 10022219
[TBL] [Abstract][Full Text] [Related]
40. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
